Evidence map›Paper›PMID 27041776›Full record

ArticleTetrahedron letters2016

Synthesis of 2-aryl-2H-tetrazoles via a regioselective [3+2] cycloaddition reaction.

Remi Patouret, Theodore M Kamenecka

Abstract read
In one paragraph

Article in Tetrahedron letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Remi PatouretThe Scripps Research Institute, Scripps Florida, Department of Molecular Therapeutics, 130 Scripps Way #A2A, Jupiter, FL 33458, USA.
Theodore M KameneckaThe Scripps Research Institute, Scripps Florida, Department of Molecular Therapeutics, 130 Scripps Way #A2A, Jupiter, FL 33458, USA.

Funding

Optimizing Drug-like PropertiesP01DA033622 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI KAMENECKA, THEODORE M, KENNY, PAUL J. · 2012 to 2016
$8.3M
Mass spectrometry for small molecule profiling in the Scripps Florida DMPK coreS10OD010603 · OD · SCRIPPS FLORIDA · PI CAMERON, MICHAEL DARIN · 2013 to 2013
$461k
NIDA NIH HHS P01 DA033622NIH HHS S10 OD010603
6 · The paper itself

Abstract

A regioselective cycloaddition reaction of arenediazonium salts with trimethylsilyldiazomethane is reported. A series of 2-aryltetrazoles were obtained in good to moderate yields with wide functional group compatibility. Furthermore, this cycloaddition reaction opens the way to build up the versatile intermediate 2-aryl-5-bromotetrazole.

Indexed as

2H-Tetrazole[3+2] CycloadditionSilver catalysisTrimethylsilyldiazomethane

Identifiers

PMID27041776
PMCPMC4810784

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.